Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study.
Kenichi NakajimaAtsushi MizokamiHideyasu MatsuyamaTomohiko IchikawaGo KanekoSatoru TakahashiHiroaki ShiinaHiroyuki HorikoshiKatsuyoshi HashineYutaka SugiyamaTakeshi MiyaoManabu KamiyamaKenichi HaradaAkito Itonull nullPublished in: International journal of urology : official journal of the Japanese Urological Association (2021)
The Bone Scan Index and hot spot number are significant determinants of 3-year mortality, and combining the Bone Scan Index with prostate-specific antigen should contribute to the management of prostate cancer patients with bone metastasis.
Keyphrases
- prostate cancer
- bone mineral density
- radical prostatectomy
- computed tomography
- bone loss
- soft tissue
- bone regeneration
- postmenopausal women
- squamous cell carcinoma
- body composition
- type diabetes
- risk factors
- adipose tissue
- radiation therapy
- skeletal muscle
- magnetic resonance
- polycystic ovary syndrome
- benign prostatic hyperplasia